Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
27.89
-1.91 (-6.41%)
At close: May 15, 2026, 4:00 PM EDT
27.93
+0.04 (0.14%)
After-hours: May 15, 2026, 6:31 PM EDT

Tectonic Therapeutic Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
21.7220.5516.657.6833.2535.73
Research & Development
71.3263.4941.3636.9772.1983.11
Total Operating Expenses
93.0484.0458.0244.65105.43118.84
Operating Income
-93.04-84.04-58.02-44.65-105.43-118.84
Interest Income
11.0311.34.260.58--
Interest Expense
-0.05-0.06-0.11-0.15--
Other Non-Operating Income (Expense)
-0.2-0.12-4.121.4-0.46-0.29
Total Non-Operating Income (Expense)
10.7811.120.031.83-0.46-0.29
Pretax Income
-82.26-72.92-57.98-42.82-105.89-119.13
Provision for Income Taxes
1.231.23----
Net Income
-83.49-74.15-57.98-42.82-105.89-119.13
Net Income to Common
-83.49-74.15-57.98-42.82-105.89-119.13
Shares Outstanding (Basic)
19188124
Shares Outstanding (Diluted)
19188124
Shares Change (YoY)
51.16%115.81%569.30%-35.59%-44.85%18.36%
EPS (Basic)
-4.46-4.05-6.83-33.76-16.34-33.36
EPS (Diluted)
-4.46-4.05-6.83-33.76-16.34-33.36
Shares Outstanding
18.8318.7414.862.633.663.64
Free Cash Flow
-65.61-60.29-59.24-40.96-97.48-100.49
Free Cash Flow Per Share
-3.50-3.29-6.98-32.29-49.49-28.14
EBITDA
-91.72-82.66-56.37-43.17-103.99-117.44
EBIT
-93.04-84.04-58.02-44.65-105.43-118.84
Effective Tax Rate
-1.50%-1.69%0.00%0.00%0.00%0.00%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q